Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Hung Carol Tan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Cureus|April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database InitiativeBrian Won, George B Carey, Yi-Hung Carol Tan, et al.
International Journal of Medical Sciences|June 27, 2013
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosisJiunn-Min Shieh, Yen-An Tang, Tsung-Han Yang, et al.
Cancer|September 21, 2021
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitorsCorey C Foster, Marcus A Couey, Sara E Kochanny, et al.
Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.
Genes, Chromosomes & Cancer|May 16, 2012
Differential expression of RON in small and non-small cell lung cancersRajani Kanteti, Soundararajan Krishnaswamy, Daniel Catenacci, et al.
Plos One|September 22, 2010
A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancerYen-An Tang, Wei-Ling Wen, Jer-Wei Chang, et al.
Scientific Reports|June 16, 2015
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerBenjamin D Ferguson, Yi-Hung Carol Tan, Rajani S Kanteti, et al.
Oncotarget|June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinomaCleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Cureus|April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database InitiativeBrian Won, George B Carey, Yi-Hung Carol Tan, et al.
International Journal of Medical Sciences|June 27, 2013
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosisJiunn-Min Shieh, Yen-An Tang, Tsung-Han Yang, et al.
Cancer|September 21, 2021
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitorsCorey C Foster, Marcus A Couey, Sara E Kochanny, et al.
Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.
Genes, Chromosomes & Cancer|May 16, 2012
Differential expression of RON in small and non-small cell lung cancersRajani Kanteti, Soundararajan Krishnaswamy, Daniel Catenacci, et al.
Plos One|September 22, 2010
A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancerYen-An Tang, Wei-Ling Wen, Jer-Wei Chang, et al.
Scientific Reports|June 16, 2015
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerBenjamin D Ferguson, Yi-Hung Carol Tan, Rajani S Kanteti, et al.
Oncotarget|June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinomaCleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Pageof 2